University of Ioannina
Ανάπτυξη και επικύρωση αναλυτικών μεθοδολογιών προσδιορισμού αντικαταθλιπτικών και αντιψυχωσικών φαρμάκων σε νεκροτομικό υλικό και βιολογικά υγρά ασθενών
Abstract
dc:descriptionThe antipsychotic and antidepressant drugs are two classes of prescribed medication with central nervous system action. They are prescribed for the treatment of different psychotic disorders, primarily schizophrenia and depression. These classes of xenobiotic compounds are of significant interest in the fields of Clinical and Forensic Toxicology. The determination of APs and ADs in clinical samples from psychiatric patients could contribute to the monitoring of therapeutic drug levels. Uncertain drug adherence, suboptimal tolerability, non-response at therapeutic doses, or pharmacokinetic drug-drug interactions are typical situations revealed during therapeutic drug monitoring. Moreover, antipsychotics and antidepressants can cause severe side effects to the psychiatric patient, even death. Furthermore, they are accused for significant increase in suicidal ideation and subsequent suicidal attempts. In addition, poisonings due to psychiatric drugs can frequently occur worldwide especially in countries with developed economies and health systems. Poisonings could be the result either of suicide attempts or accidental ingestions. Therefore, APs and ADs are included among the drugs routinely screened for during postmortem toxicological analyses. For all the aforementioned reasons, the development of analytical methods for the qualitative and quantitative determination of these drugs in clinical and postmortem specimens is very significant.In this contribution, eight antipsychotic drugs (olanzapine, haloperidol, amisulpride, risperidone, paliperidone, clozapine-with metabolite N-desmethylclozapine-, quetiapine and aripiprazole), nine antidepressants (mirtazapine, bupropion, venlafaxine, citalopram, (with metabolite N-desmethylcitalopram), paroxetine, duloxetine, agomelatine, sertraline (with metabolite N-desmethylsertraline) and clomipramine were included as target analytes for new method development.Initially, different extraction procedures (LLE, SPE), for the isolation of analytes from biological samples (plasma, serum, whole blood, urine and liver tissue), were optimized. The extracts were analyzed further either with gas (GC) or with liquid chromatography (LC). The proposed analytical protocols were validated by applying international guidelines. The validation criteria were the following: selectivity, specificity linearity, accuracy, precision, detectability and stability.More specifically, a new SPE-GC-MS method was developed for the quantification of nine analytes, (antipsychotics: haloperidol, olanzapine, clozapine and antidepressants: mirtazapine, bupropion, venlafaxine, citalopram, sertraline clomipramine), with high selectivity, accuracy, precision and relative low cost and rapid quantification.In addition, a new SPE(LLE)-UHPLC-UV/DAD method was developed for the quantification of 19 analytes (antipsychotics: olanzapine, amisulpride, risperidone, paliperidone, clozapine, Ν-desmethylclozapine, quetiapine, aripiprazole and antidepressants: mirtazapine, bupropion, venlafaxine, citalopram, N-desmethylcitalopram, paroxetine, duloxetine, agomelatine, sertraline, N-desmethylsertraline, clomipramine); the LC method was validated with the same analytical criteria as the GC method.It is worth mentioning, that the SPE(LLE)-UHPLC-UV/DAD method is the only one far which ensures the quantitative determination of agomelatine (one of the most modern antidepressants) in postmortem material, to the best of our knowledge.The developed analytical methods were successfully applied for the determination of the selected antipsychotics and antidepressants in clinical samples from psychiatric patients, under antipsychotic medication, as well as, in postmortem specimens, sampled during autopsy for routine death investigation processes.The analysis of clinical samples revealed, that relatively high frequencies of samples had concentrations of antipsychotics lower or higher than respective therapeutic ranges. More specifically, the mean concentrations of aripiprazole, quetiapine and risperidone were lower than the lower values of the respective therapeutic range levels. Furthermore, the concentrations of clozapine in some samples were higher than the higher value of the respective therapeutic window. These findings indicate that the measurement of antipsychotics level can be a useful tool for the optimization of psychopharmacotherapy and a significant contributor to the individualized medicine.Last but not least, the proposed methodologies were proved suitable for postmortem toxicological investigations and confirmed the importance of accurate and sensitive analytical methods for the determination of APs and ADs in biological specimens, order to contribute the forensic investigation of postmortem cases.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Rallis, Georgios
- Ράλλης, Γεώργιος
Subjects
dc:subject × 24- Δικαστική τοξικολογία
- Κλινική τοξικολογία
- Αντιψυχωσικά
- Αντικαταθλιπτικά
- Νεκροτομικό υλικό
- Βιολογικά υγρά ασθενών
- Επίπεδα φαρμάκων
- Ανάπτυξη αναλυτικής μεθοδολογίας
- Forensic toxicology
- Clinical toxicology
- Antipsychotics
- Antidepressants
- Postmortem material
- Clinical specimens
- Drug levels
- Analytical method development
- Φυσικές Επιστήμες
- Χημεία
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Natural Sciences
- Chemical Sciences
- Medical and Health Sciences
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/43839